Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 23, 2015 08:00 ET | Source: CareDx, Inc.

CareDx Completes Analytical Validation of AlloSure: A Next-Generation Sequencing Test Measuring Donor-Derived Cell-Free DNA in Transplant Patients

BRISBANE, Calif., Dec. 23, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
December 16, 2015 05:02 ET | Source: CareDx, Inc.

CareDx Announces Agreement to Purchase 78 Percent of the Outstanding Shares of Allenex AB and Plans to Launch Tender for Remaining Shares in First Quarter 2016

BRISBANE, Calif., Dec. 16, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
November 17, 2015 18:35 ET | Source: CareDx, Inc.

CMS Revises Its Pricing Determination for AlloMap(R)

Reimbursement for Heart Transplant Surveillance Testing to Remain At Previous Level Decision is Victory for Transplant Community BRISBANE, Calif., Nov. 17, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc....
November 17, 2015 16:05 ET | Source: CareDx, Inc.

CareDx to Participate in Upcoming Investor Conferences

BRISBANE, Calif., Nov. 17, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
November 11, 2015 16:05 ET | Source: CareDx, Inc.

CareDx, Inc. Reports Third Quarter 2015 Financial Results

BRISBANE, Calif., Nov. 11, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
November 09, 2015 16:52 ET | Source: CareDx, Inc.

CareDx Presents Donor-Derived Cell-Free DNA Data at the Association for Molecular Pathology and American Society of Nephrology Annual Meetings

BRISBANE, Calif., Nov. 9, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated,...
November 02, 2015 17:14 ET | Source: CareDx, Inc.

CareDx Completes Expansion of CLIA Laboratory With Next-Generation Sequencing Platform Capability

BRISBANE, Calif., Nov. 2, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated,...
October 28, 2015 16:02 ET | Source: CareDx, Inc.

CareDx to Release Third Quarter 2015 Financial Results and Host Conference Call on November 11, 2015

BRISBANE, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
October 18, 2015 18:00 ET | Source: CareDx, Inc.

CareDx CEO to Present at CMS Panel Meeting on Monday, October 19 at 8:45am ET

BRISBANE, Calif., Oct. 18, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
October 15, 2015 18:19 ET | Source: CareDx, Inc.

CareDx Announces New Clinical Data on AlloMap Score Variability and Service to Support Assessment of Long-Term Transplant Recipient Risk

BRISBANE, Calif., Oct. 15, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...